Literature DB >> 26392655

Diversity and antifungal resistance patterns of prevalent opportunistic pathogenic yeasts colonizing the oral cavities of asymptomatic human immunodeficiency virus-infected individuals, and their relation to CD4(+) counts.

Deepa Anil Kumar1, Sumathi Muralidhar2, Uma Banerjee3, Seemi Farhat Basir1, Purva Mathur4, Luqman Ahmad Khan1.   

Abstract

BACKGROUND: Yeasts are important opportunistic pathogens, in individuals infected with human immunodeficiency virus (HIV). Yeast species inhabiting the oral mucosa of HIV-infected persons can act as source of oral lesions, especially as the individual progresses towards immunocompromised state. Present study was conducted to evaluate the diversity of yeasts in oral cavities of asymptomatic HIV-infected persons and their association with CD4(+) cell counts.
MATERIALS AND METHODS: 100 HIV seropositive subjects and 100 healthy controls were screened for oral yeast carriage using standard procedures.
RESULTS: Of the 100 HIV-seropositive persons screened, 48 were colonized by different yeasts, either alone or in association with another species. Candida albicans was the most common species (56.90%) while non C. albicans Candida (NCAC) accounted for 39.65%. Among NCAC, Candida tropicalis and Candida krusei were most common. One isolate each of rare opportunistic pathogenic yeasts, Geotrichum candidum and Saccharomyces cereviseae, was recovered. The control group had an oral candidal carriage rate of 23%; C. albicans was the predominant species, followed by Candida glabrata, C. tropicalis and Candida parapsilosis. Antifungal susceptibility testing revealed no resistance in C. albicans, to the commonly used antifungal agents, whereas resistance or dose dependent susceptibility to fluconazole was observed in some of the NCAC species.
CONCLUSION: Oral carriage of opportunistic pathogenic yeasts was greater in HIV-seropositive persons heading towards immunocompromised state, as evidenced by their CD4(+) cell count. The predominant yeast isolated in this study (C. albicans), was found to be susceptible to commonly used antifungals.

Entities:  

Keywords:  Antifungal susceptibility test; CD4+ count; human immunodeficiency virus; opportunistic infections; oral candidiasis; oral yeast carriage; seropositive

Year:  2015        PMID: 26392655      PMCID: PMC4555900          DOI: 10.4103/0253-7184.156724

Source DB:  PubMed          Journal:  Indian J Sex Transm Dis AIDS        ISSN: 2589-0557


  14 in total

1.  Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients.

Authors:  Ali Abdul Lattif; Uma Banerjee; Rajendra Prasad; Ashutosh Biswas; Naveet Wig; Neeraj Sharma; Absarul Haque; Nivedita Gupta; Najma Z Baquer; Gauranga Mukhopadhyay
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Species distribution & antifungal susceptibility of oral Candida colonising or infecting HIV infected individuals.

Authors:  Arti Mane; Sapna Panchvalli; Shilpa Bembalkar; Arun Risbud
Journal:  Indian J Med Res       Date:  2010-06       Impact factor: 2.375

3.  Tween 80 opacity test responses of various Candida species.

Authors:  M Slifkin
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Oral geotrichosis: report of 12 cases.

Authors:  Alexandro Bonifaz; Denisse Vázquez-González; Berenice Macías; Fernando Paredes-Farrera; Marco A Hernández; Javier Araiza; Rosa M Ponce
Journal:  J Oral Sci       Date:  2010-09       Impact factor: 1.556

5.  Asymptomatic oral carriage of Candida species in HIV-infected patients in the highly active antiretroviral therapy era.

Authors:  Carolina Rodrigues Costa; Ana Joaquina Cohen; Orionalda Fátima Lisboa Fernandes; Karla Carvalho Miranda; Xisto Sena Passos; Lúcia Kioko Hasimoto Souza; Maria do Rosário Rodrigues Silva
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2006 Sep-Oct       Impact factor: 1.846

6.  Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana.

Authors:  Francis Kwamin; Nii Otu Nartey; Francis S Codjoe; Mercy J Newman
Journal:  J Infect Dev Ctries       Date:  2013-01-15       Impact factor: 0.968

7.  Oral microflora and their relation to risk factors in HIV+ patients with oropharyngeal candidiasis.

Authors:  A Sharifzadeh; A R Khosravi; H Shokri; F Asadi Jamnani; M Hajiabdolbaghi; I Ashrafi Tamami
Journal:  J Mycol Med       Date:  2013-05-27       Impact factor: 2.391

8.  Geographical differences in human oral yeast flora.

Authors:  Jianping Xu; Thomas G Mitchell
Journal:  Clin Infect Dis       Date:  2002-12-19       Impact factor: 9.079

9.  Oropharyngeal carriage of Candida species in HIV-infected patients in India.

Authors:  H C Gugnani; K Becker; W Fegeler; S Basu; D Chattopadhya; U Baveja; S Satyanarayana; T Kalghatgi; A Murlidhar
Journal:  Mycoses       Date:  2003-09       Impact factor: 4.377

10.  Oropharyngeal candidiasis and Candida colonization in HIV positive patients in northern India.

Authors:  Vijeta Maurya; Ashutosh Srivastava; Jyoti Mishra; Rajni Gaind; Rungmei S K Marak; Anil Kumar Tripathi; Mastan Singh; Vimala Venkatesh
Journal:  J Infect Dev Ctries       Date:  2013-08-15       Impact factor: 0.968

View more
  1 in total

1.  Clinico-mycological analysis and antifungal resistance pattern in human immunodeficiency virus-associated candidiasis: An Indian perspective.

Authors:  Ravinder Kaur; Bhanu Mehra; Megh Singh Dhakad; Ritu Goyal; Preena Bhalla; Richa Dewan
Journal:  Indian J Sex Transm Dis AIDS       Date:  2018 Jul-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.